Paritaprevir (ABT-450)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Paritaprevir (ABT-450), covering 2014-02-19 to 2017-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults [Phase 2]